title: Cloxyquin (5-chloroquinolin-8-ol) is an activator of the two-pore domain potassium channel TRESK.
abstract: TRESK is a two-pore domain potassium channel. Loss of function mutations have been linked to typical migraine with aura and due to TRESK’s expression pattern and role in neuronal excitability it represents a promising therapeutic target. We developed a cell based assay using baculovirus transduced U20S cells to screen for activators of TRESK. Using a thallium flux system to measure TRESK channel activity we identified Cloxyquin as a novel activator. Cloxyquin was shown to have an EC50 of 3.8 μM in the thallium assay and displayed good selectivity against other potassium channels tested. Activity was confirmed using whole cell patch electrophysiology, with Cloxyquin causing a near two fold increase in outward current. The strategy presented here will be used to screen larger compound libraries with the aim of identifying novel chemical series which may be developed into new migraine prophylactics.
authors.forename: Paul D
authors.initials: PD
authors.lastname: Wright
authors.forename: Gregory
authors.initials: G
authors.lastname: Weir
authors.forename: Jamie
authors.initials: J
authors.lastname: Cartland
authors.forename: David
authors.initials: D
authors.lastname: Tickle
authors.forename: Catherine
authors.initials: C
authors.lastname: Kettleborough
authors.forename: M Zameel
authors.initials: MZ
authors.lastname: Cader
authors.forename: Jeff
authors.initials: J
authors.lastname: Jerman
mesh_terms: D000818:Animals; D002460:Cell Line; D002739:Chloroquinolinols / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D018408:Patch-Clamp Techniques; D015221:Potassium Channels / Q000819:agonists*; D054852:Small Molecule Libraries / Q000737:chemistry / Q000494:pharmacology*
chemical_list: D002739:Chloroquinolinols; C476574:KCNK18 protein, human; D015221:Potassium Channels; D054852:Small Molecule Libraries; C519493:cloxyquin